| Innate sensing of oxidation-specific epitopes in health and disease CJ Binder, N Papac-Milicevic, JL Witztum Nature Reviews Immunology 16 (8), 485-497, 2016 | 342 | 2016 |
| Interleukin‐13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype L Cardilo‐Reis, S Gruber, SM Schreier, M Drechsler, N Papac‐Milicevic, ... EMBO molecular medicine 4 (10), 1072-1086, 2012 | 300 | 2012 |
| Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNFα-induced PAI-1 expression F Gruber, P Hufnagl, R Hofer-Warbinek, JA Schmid, JM Breuss, ... Blood, The Journal of the American Society of Hematology 101 (8), 3042-3048, 2003 | 149 | 2003 |
| Malondialdehyde epitopes as targets of immunity and the implications for atherosclerosis N Papac-Milicevic, CJL Busch, CJ Binder Advances in immunology 131, 1-59, 2016 | 123 | 2016 |
| Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies1 [S] D Tsiantoulas, T Perkmann, T Afonyushkin, A Mangold, TA Prohaska, ... Journal of lipid research 56 (2), 440-448, 2015 | 116 | 2015 |
| Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH T Hendrikx, F Porsch, MG Kiss, D Rajcic, N Papac-Miličević, C Hoebinger, ... Journal of hepatology 77 (5), 1373-1385, 2022 | 78 | 2022 |
| Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice CJL Busch, T Hendrikx, D Weismann, S Jäckel, SMA Walenbergh, ... Hepatology 65 (4), 1181-1195, 2017 | 66 | 2017 |
| The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors N Papac-Milicevic, JM Breuss, J Zaujec, L Ryban, T Plyushch, GA Wagner, ... Circulation research 110 (8), e50-e63, 2012 | 47 | 2012 |
| A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes L Alic, N Papac-Milicevic, D Czamara, RB Rudnick, M Ozsvar-Kozma, ... Proceedings of the National Academy of Sciences 117 (18), 9942-9951, 2020 | 36 | 2020 |
| Selective EGFR (Epidermal Growth Factor Receptor) deletion in myeloid cells limits atherosclerosis—brief report L Zeboudj, A Giraud, L Guyonnet, Y Zhang, L Laurans, B Esposito, J Vilar, ... Arteriosclerosis, Thrombosis, and Vascular Biology 38 (1), 114-119, 2018 | 35 | 2018 |
| FHR5 binds to laminins, uses separate C3b and surface-binding sites, and activates complement on malondialdehyde-acetaldehyde surfaces RB Rudnick, Q Chen, ED Stea, A Hartmann, N Papac-Milicevic, F Person, ... The Journal of Immunology 200 (7), 2280-2290, 2018 | 29 | 2018 |
| The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation K Kulak, GT Westermark, N Papac-Milicevic, E Renström, AM Blom, ... Diabetologia 60, 1522-1533, 2017 | 19 | 2017 |
| C/D box snoRNA SNORD113-6/AF357425 plays a dual role in integrin signalling and arterial fibroblast function via pre-mRNA processing and 2′ O-ribose methylation E van Ingen, DAL van den Homberg, ML van der Bent, H Mei, ... Human molecular genetics 31 (7), 1051-1066, 2022 | 18 | 2022 |
| Complement factor H modulates splenic B cell development and limits autoantibody production MG Kiss, M Ozsvár-Kozma, F Porsch, L Göderle, N Papac-Miličević, ... Frontiers in Immunology 10, 1607, 2019 | 14 | 2019 |
| Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease S Irmscher, SLH Zipfel, LD Halder, L Ivanov, A Gonzalez-Delgado, ... Scientific reports 11 (1), 22511, 2021 | 12 | 2021 |
| Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis MG Kiss, N Papac-Miličević, F Porsch, D Tsiantoulas, T Hendrikx, ... Immunity 56 (8), 1809-1824. e10, 2023 | 10 | 2023 |
| C4b-binding protein inhibits particulate-and crystalline-induced NLRP3 inflammasome activation D Bierschenk, N Papac-Milicevic, IP Bresch, V Kovacic, S Bettoni, ... Frontiers in Immunology 14, 1149822, 2023 | 6 | 2023 |
| The OSE complotype and its clinical potential L Alic, CJ Binder, N Papac-Milicevic Frontiers in Immunology 13, 1010893, 2022 | 4 | 2022 |
| Can a single genetic variant explain residual cardiovascular risk by modifying NLRP3 expression? N Papac-Milicevic, CJ Binder European Heart Journal 42 (18), 1757-1759, 2021 | 1 | 2021 |
| ISG12 regulates activity of nuclear receptors thereby modulating the vascular response to injury N Papac‐Milicevic, L Ryban, J Zaujec, C Binder, J Breuss, E Binder, ... The FASEB Journal 21 (6), A903-A904, 2007 | 1 | 2007 |
